Standard
Harvard
Kristensen, SD, Fajadet, J, Di Mario, C, Kaifoszova, Z
, Laut, KG, Deleanu, D, Gilard, M, Guagliumi, G, Goktekin, O, Jorgova, J, Kanakakis, J, Ostojic, M, Pereira, H, Sabate, M, Sobhy, M, Vrints, C, Wijns, W & Widimsky, P 2012, '
Implementation of primary angioplasty in Europe: stent for life initiative progress report',
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, bind 8, nr. 1, s. 35-42.
https://doi.org/10.4244/EIJV8I1A7
APA
Kristensen, S. D., Fajadet, J., Di Mario, C., Kaifoszova, Z.
, Laut, K. G., Deleanu, D., Gilard, M., Guagliumi, G., Goktekin, O., Jorgova, J., Kanakakis, J., Ostojic, M., Pereira, H., Sabate, M., Sobhy, M., Vrints, C., Wijns, W., & Widimsky, P. (2012).
Implementation of primary angioplasty in Europe: stent for life initiative progress report.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology,
8(1), 35-42.
https://doi.org/10.4244/EIJV8I1A7
CBE
Kristensen SD, Fajadet J, Di Mario C, Kaifoszova Z
, Laut KG, Deleanu D, Gilard M, Guagliumi G, Goktekin O, Jorgova J, et al. 2012.
Implementation of primary angioplasty in Europe: stent for life initiative progress report.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 8(1):35-42.
https://doi.org/10.4244/EIJV8I1A7
MLA
Vancouver
Author
Bibtex
@article{321463791c6a4f3e8c491d9eef7c82ec,
title = "Implementation of primary angioplasty in Europe: stent for life initiative progress report",
abstract = "Primary percutaneous coronary intervention (PPCI) is the recommended treatment for patients with acute ST-segment elevation myocardial infarction (STEMI). Despite substantial evidence of its effectiveness, a 2007 study reported that only 40-45% of European STEMI patients were treated with PPCI, with large variations in treatment availability between countries. In 2008, the Stent for Life (SFL) initiative was launched by the European Association of Percutaneous Cardiovascular Interventions and EuroPCR in partnership with the European Society of Cardiology (ESC) Working Group on Acute Cardiac Care and country-specific national cardiac societies. The aim is to promote the prioritisation of percutaneous coronary intervention treatment towards those who will benefit most, namely STEMI patients. The following countries are currently participating: Bulgaria, Egypt, France, Greece, Italy, Portugal, Romania, Serbia, Spain and Turkey.",
author = "Kristensen, {Steen Dalby} and Jean Fajadet and {Di Mario}, Carlo and Zuzana Kaifoszova and Laut, {Kristina Gr{\o}nborg} and Dan Deleanu and Martine Gilard and Giulio Guagliumi and Omer Goktekin and Julia Jorgova and John Kanakakis and Miodrag Ostojic and Helder Pereira and Manel Sabate and Mohamed Sobhy and Christiaan Vrints and William Wijns and Petr Widimsky",
year = "2012",
doi = "10.4244/EIJV8I1A7",
language = "English",
volume = "8",
pages = "35--42",
journal = "EuroIntervention",
issn = "1774-024X",
publisher = "Europa Digital & Publishing",
number = "1",
}
RIS
TY - JOUR
T1 - Implementation of primary angioplasty in Europe
T2 - stent for life initiative progress report
AU - Kristensen, Steen Dalby
AU - Fajadet, Jean
AU - Di Mario, Carlo
AU - Kaifoszova, Zuzana
AU - Laut, Kristina Grønborg
AU - Deleanu, Dan
AU - Gilard, Martine
AU - Guagliumi, Giulio
AU - Goktekin, Omer
AU - Jorgova, Julia
AU - Kanakakis, John
AU - Ostojic, Miodrag
AU - Pereira, Helder
AU - Sabate, Manel
AU - Sobhy, Mohamed
AU - Vrints, Christiaan
AU - Wijns, William
AU - Widimsky, Petr
PY - 2012
Y1 - 2012
N2 - Primary percutaneous coronary intervention (PPCI) is the recommended treatment for patients with acute ST-segment elevation myocardial infarction (STEMI). Despite substantial evidence of its effectiveness, a 2007 study reported that only 40-45% of European STEMI patients were treated with PPCI, with large variations in treatment availability between countries. In 2008, the Stent for Life (SFL) initiative was launched by the European Association of Percutaneous Cardiovascular Interventions and EuroPCR in partnership with the European Society of Cardiology (ESC) Working Group on Acute Cardiac Care and country-specific national cardiac societies. The aim is to promote the prioritisation of percutaneous coronary intervention treatment towards those who will benefit most, namely STEMI patients. The following countries are currently participating: Bulgaria, Egypt, France, Greece, Italy, Portugal, Romania, Serbia, Spain and Turkey.
AB - Primary percutaneous coronary intervention (PPCI) is the recommended treatment for patients with acute ST-segment elevation myocardial infarction (STEMI). Despite substantial evidence of its effectiveness, a 2007 study reported that only 40-45% of European STEMI patients were treated with PPCI, with large variations in treatment availability between countries. In 2008, the Stent for Life (SFL) initiative was launched by the European Association of Percutaneous Cardiovascular Interventions and EuroPCR in partnership with the European Society of Cardiology (ESC) Working Group on Acute Cardiac Care and country-specific national cardiac societies. The aim is to promote the prioritisation of percutaneous coronary intervention treatment towards those who will benefit most, namely STEMI patients. The following countries are currently participating: Bulgaria, Egypt, France, Greece, Italy, Portugal, Romania, Serbia, Spain and Turkey.
U2 - 10.4244/EIJV8I1A7
DO - 10.4244/EIJV8I1A7
M3 - Journal article
C2 - 22580247
VL - 8
SP - 35
EP - 42
JO - EuroIntervention
JF - EuroIntervention
SN - 1774-024X
IS - 1
ER -